Thrivent Financial for Lutherans’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Buy |
|
|||||
|
2025
Q1 | $1.33M | Sell |
|
|||||
|
2024
Q4 | $1.54M | Sell |
|
|||||
|
2024
Q3 | $1.35M | Sell |
|
|||||
|
2024
Q2 | $1.22M | Sell |
|
|||||
|
2024
Q1 | $1.62M | Sell |
|
|||||
|
2023
Q4 | $1.41M | Sell |
|
|||||
|
2023
Q3 | $1.38M | Sell |
|
|||||
|
2023
Q2 | $1.57M | Sell |
|
|||||
|
2023
Q1 | $1.94M | Sell |
|
|||||
|
2022
Q4 | $1.98M | Buy |
|
|||||
|
2022
Q3 | $1.87M | Buy |
|
|||||
|
2022
Q2 | $1.52M | Buy |
|
|||||
|
2022
Q1 | $1.4M | Buy |
|
|||||
|
2021
Q4 | $1.26M | Buy |
|
|||||
|
2021
Q3 | $1.15M | Sell |
|
|||||
|
2021
Q2 | $1.33M | Sell |
|
|||||
|
2021
Q1 | $1.14M | Sell |
|
|||||
|
2020
Q4 | $1.1M | Sell |
|
|||||
|
2020
Q3 | $910K | Sell |
|
|||||
|
2020
Q2 | $1.04M | Hold |
|
|||||
|
2020
Q1 | $791K | Buy |
|
|||||
|
2019
Q4 | $991K | Buy |
|
|||||
|
2019
Q3 | $1.15M | Buy |
|
|||||
|
2019
Q2 | $1.36M | Buy |
|
|||||
|
2019
Q1 | $1.4M | Buy |
|
|||||
|
2018
Q4 | $1.23M | Buy |
|
|||||
|
2018
Q3 | $1.83M | Buy |
|
|||||
|
2018
Q2 | $2.13M | Buy |
|
|||||
|
2018
Q1 | $1.59M | Buy |
|
|||||
|
2017
Q4 | $1.26M | Buy |
|
|||||
|
2017
Q3 | $1.24M | Buy |
|
|||||
|
2017
Q2 | $1.31M | Buy |
|
|||||
|
2017
Q1 | $880K | Buy |
|
|||||
|
2016
Q4 | $664K | Buy |
|
|||||
|
2016
Q3 | $628K | Buy |
|
|||||
|
2016
Q2 | $350K | Buy |
|
|||||
|
2016
Q1 | $233K | Buy |
|
|||||
|
2015
Q4 | $199K | Buy |
|